Arthropathy in thalassaemia patients receiving deferiprone
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference10 articles.
1. Development of iron-chelating agents for clinical use;Brittenham;Blood,1992
2. Fatal systemic lupus erythematosus in patient taking oral iron chelator L1;Mehta;Lancet,1991
3. Anti-nuclear antibodies in patients taking L1;Berdoukas;Lancet,1991
4. Efficacy and possible adverse effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in thalassaemia major;Al-Refaie;Blood,1992
5. Long-term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion-dependent thalassaemia: Indian trial;Agarwal;Br J Haematol,1992
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Musculoskeletal Disorders;Radiation Therapy of Benign Diseases;2023
2. The effect of ferritin levels on distal femoral cartilage thickness in patients with beta thalassaemia major;Journal of Bone and Mineral Metabolism;2022-11-24
3. Prevalence and characteristics of inflammatory rheumatic diseases in patients with thalassemia;Annals of Hematology;2022-05-23
4. Thalassemia and autoimmune diseases: Absence of evidence or evidence of absence?;Blood Reviews;2021-08
5. Therapeutic applications of chelating drugs in iron metabolic disorders of the brain and retina;Journal of Neuroscience Research;2020-07-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3